These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 7459856

  • 1. Cytotoxic and cytokinetic effects of 1-beta-D-arabinofuranosylcytosine, daunorubicin, and 6-thioguanine on HeLa cells in culture.
    Fried J, Perez AG, Doblin JM, Clarkson BD.
    Cancer Res; 1981 Mar; 41(3):1127-32. PubMed ID: 7459856
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Reduction of 1-beta-D-arabinofuranosylcytosine and adriamycin cytotoxicity following cell cycle arrest by anguidine.
    Teodori L, Barlogie B, Drewinko B, Swartzendruber D, Mauro F.
    Cancer Res; 1981 Apr; 41(4):1263-70. PubMed ID: 7214318
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cytotoxic and cytokinetic effects of thymidine, 5-fluorouracil, and deoxycytidine on HeLa cells in culture.
    Fried J, Perez AG, Doblin JM, Clarkson BD.
    Cancer Res; 1981 Jul; 41(7):2627-32. PubMed ID: 7248935
    [Abstract] [Full Text] [Related]

  • 7. Macromolecular and cell cycle effects of different classes of agents inducing the maturation of human myeloblastic leukemia (ML-1) cells.
    Craig RW, Frankfurt OS, Sakagami H, Takeda K, Bloch A.
    Cancer Res; 1984 Jun; 44(6):2421-9. PubMed ID: 6586286
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Factors modifying the synergistic toxicity of deoxycytidine in combination with thymidine plus 5-fluorouracil in HeLa cells.
    Fried J, Perez AG, Doblin JM, Clarkson BD.
    Cell Tissue Kinet; 1983 Nov; 16(6):539-48. PubMed ID: 6627345
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Evaluation of cell-killing effects of 1-beta-D-arabinofuranosylcytosine and daunorubicin by a new computer-controlled in vitro pharmacokinetic simulation system.
    Kishi S, Goto N, Nakamura T, Ueda T.
    Cancer Res; 1999 Jun 01; 59(11):2629-34. PubMed ID: 10363985
    [Abstract] [Full Text] [Related]

  • 13. Selective protection by anguidine of normal versus transformed cells against 1-beta-D-arabinofuranosylcytosine and Adriamycin.
    Hromas R, Barlogie B, Swartzendruber D, Drewinko B.
    Cancer Res; 1983 Mar 01; 43(3):1135-7. PubMed ID: 6825085
    [Abstract] [Full Text] [Related]

  • 14. Chemopotentiating effects of a novel NAD biosynthesis inhibitor, FK866, in combination with antineoplastic agents.
    Pogrebniak A, Schemainda I, Azzam K, Pelka-Fleischer R, Nüssler V, Hasmann M.
    Eur J Med Res; 2006 Aug 30; 11(8):313-21. PubMed ID: 17052966
    [Abstract] [Full Text] [Related]

  • 15. Determinants of sensitivity to 1-beta-D-arabinofuranosylcytosine in HCT 116 and NCI-H630 human colon carcinoma cells.
    Grem JL, Geoffroy F, Politi PM, Cuddy DP, Ross DD, Nguyen D, Steinberg SM, Allegra CJ.
    Mol Pharmacol; 1995 Aug 30; 48(2):305-15. PubMed ID: 7651364
    [Abstract] [Full Text] [Related]

  • 16. [Damage of vascular endothelium in the treatment of acute leukemia: in vitro study].
    Romanov IuA, Chervontseva AM, Savchenko VG.
    Ter Arkh; 2004 Aug 30; 76(7):34-40. PubMed ID: 15379125
    [Abstract] [Full Text] [Related]

  • 17. Cell cycle related uptake, retention and toxicity of idarubicin, daunorubicin and doxorubicin.
    Minderman H, Linssen P, Wessels J, Haanen C.
    Anticancer Res; 1993 Aug 30; 13(4):1161-5. PubMed ID: 8352539
    [Abstract] [Full Text] [Related]

  • 18. The role of human nucleoside transporters in cellular uptake of 4'-thio-beta-D-arabinofuranosylcytosine and beta-D-arabinosylcytosine.
    Clarke ML, Damaraju VL, Zhang J, Mowles D, Tackaberry T, Lang T, Smith KM, Young JD, Tomkinson B, Cass CE.
    Mol Pharmacol; 2006 Jul 30; 70(1):303-10. PubMed ID: 16617163
    [Abstract] [Full Text] [Related]

  • 19. Dysregulation of the cyclin-dependent kinase inhibitor p21WAF1/CIP1/MDA6 increases the susceptibility of human leukemia cells (U937) to 1-beta-D-arabinofuranosylcytosine-mediated mitochondrial dysfunction and apoptosis.
    Wang Z, Van Tuyle G, Conrad D, Fisher PB, Dent P, Grant S.
    Cancer Res; 1999 Mar 15; 59(6):1259-67. PubMed ID: 10096557
    [Abstract] [Full Text] [Related]

  • 20. The effects of inhibitors of DNA biosynthesis on the cytotoxicity of 6-thioguanine.
    Lee SH, Sartorelli AC.
    Cancer Biochem Biophys; 1981 Mar 15; 5(3):189-94. PubMed ID: 6455192
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.